|
MARCH7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.09639999998657E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.13259999957283E-07 |
| Normal-vs-Stage2 |
9.738400E-02 |
| Normal-vs-Stage3 |
4.379600E-03 |
| Normal-vs-Stage4 |
1.211830E-01 |
| Stage1-vs-Stage2 |
2.218200E-01 |
| Stage1-vs-Stage3 |
4.731800E-01 |
| Stage1-vs-Stage4 |
2.866600E-01 |
| Stage2-vs-Stage3 |
6.217000E-01 |
| Stage2-vs-Stage4 |
9.178000E-01 |
| Stage3-vs-Stage4 |
5.837800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.39310000002446E-06 |
| Normal-vs-AfricanAmerican |
6.861000E-03 |
| Normal-vs-Asian |
2.120200E-01 |
| Caucasian-vs-AfricanAmerican |
2.258000E-01 |
| Caucasian-vs-Asian |
3.947000E-01 |
| AfricanAmerican-vs-Asian |
7.380400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.46270000001003E-07 |
| Normal-vs-Female |
1.070000E-01 |
| Male-vs-Female |
1.553660E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.042870E-03 |
| Normal-vs-Extreme_Weight |
1.88370000042681E-07 |
| Normal-vs-Obese |
1.756440E-03 |
| Normal-vs-Extreme_Obese |
2.702200E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.321770E-01 |
| Normal_Weight-vs-Obese |
7.106400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.599400E-01 |
| Extreme_Weight-vs-Obese |
4.596000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.728200E-01 |
| Obese-vs-Extreme_Obese |
6.056400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.214600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.579700E-04 |
| Normal-vs-Age(61-80Yrs) |
3.0508000004037E-07 |
| Normal-vs-Age(81-100Yrs) |
2.019600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.253420E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.738110E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.123500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.686100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.757800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.893800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.43270000050467E-07 |
| Normal-VS-Type2 PRCC |
1.194760E-04 |
| Normal-VS-KIRP CIMP |
6.141600E-01 |
| Normal-VS-Unclassified PRCC |
4.098000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.803000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.171600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.105440E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.882810E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.603200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.411800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.16319999998726E-06 |
| Normal-vs-N1 |
7.919400E-01 |
| Normal-vs-N2 |
2.575800E-02 |
| N0-vs-N1 |
1.926450E-02 |
| N0-vs-N2 |
9.333400E-01 |
| N1-vs-N2 |
3.279800E-01 |
|
|
